Usefulness of C-Reactive Protein and Interleukin-6 as Predictors of Outcomes in Patients With Chronic Obstructive Pulmonary Disease Receiving Pravastatin
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference14 articles.
1. Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l an analysis of the PROVE-IT TIMI-22 trial;Ridker;J Am Coll Cardiol,2005
2. C-reactive protein levels and outcomes after statin therapy;Ridker;N Engl J Med,2005
3. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases?;Sin;Circulation,2003
4. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects;Yende;Thorax,2006
5. Raised CRP levels mark metabolic and functional impairment in advanced COPD;Broekhuizen;Thorax,2006
Cited by 108 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of statins on pulmonary function in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials;Journal of Thoracic Disease;2023-07
2. Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats;Canadian Respiratory Journal;2022-04-15
3. Evaluation of selected IL6/STAT3 pathway molecules and miRNA expression in chronic obstructive pulmonary disease;Scientific Reports;2021-11-23
4. No Independent Influence of Statins on the Chronic Obstructive Pulmonary Disease Exacerbation Rate: A Cohort Observation Study Over 10 Years;International Journal of General Medicine;2021-06
5. Management of the COPD Patient with Comorbidities: An Experts Recommendation Document;International Journal of Chronic Obstructive Pulmonary Disease;2020-05
Management of the COPD Patient with Comorbidities: An Experts Recommendation Document
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3